TY - JOUR
T1 - Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure
T2 - Results of the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF)
AU - Fonarow, Gregg C.
AU - Abraham, William T.
AU - Albert, Nancy M.
AU - Gattis Stough, Wendy
AU - Gheorghiade, Mihai
AU - Greenberg, Barry H.
AU - O'Connor, Christopher M.
AU - Pieper, Karen
AU - Sun, Jie Lena
AU - Yancy, Clyde W.
AU - Young, James B.
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2007/7/23
Y1 - 2007/7/23
N2 - Background: Despite evidence-based national guidelines for optimal treatment of heart failure (HF), the quality of care remains inadequate. We sought to evaluate the effect of a national hospital-based initiative on quality of care in patients hospitalized with HF. Methods: Two hundred fifty-nine US hospitals participating in the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) submitted data on 48 612 patients with HF from March 1, 2003, through December 31, 2004. Admission, hospital, discharge care, and outcomes data were collected using a Web-based registry that provided real-time feedback on performance measures bench-marked to other hospitals. Process-of-care improvement tools, including evidence-based best-practice algorithms and customizable admission and discharge sets, were provided. Results: Provision of complete discharge instructions and smoking-cessation counseling increased significantly (from 46.8%-66.5% and 48.2%-75.6%, respectively; P<.001 for both). Left ventricular function assessment started at a high rate (89.3%) and improved to 92.1% (P<.001). Angiotensin-converting enzyme inhibitors were prescribed at discharge to 75.8% of eligible patients, which did not improve during the 2-year study. There were trends for reduction of in-hospital mortality, postdischarge death, and combined postdischarge death and rehospitalization and a significant reduction in mean length of stay. Use of preprinted admission order sets and/or discharge checklists increased from 35.6% to 54.1% and was associated with an increase in the use of evidence-based therapies and lower risk-adjusted in-hospital mortality. Conclusions: Participation in OPTIMIZE-HF was associated with an increase in use of evidence-based therapy, adherence to performance measures, and shorter lengths of stay in patients hospitalized with HF. Increased use of process-of-care improvement tools was associated with further improvements in quality of care. Trial Registration: clinicaltrials.gov Identifier NCT00344513.
AB - Background: Despite evidence-based national guidelines for optimal treatment of heart failure (HF), the quality of care remains inadequate. We sought to evaluate the effect of a national hospital-based initiative on quality of care in patients hospitalized with HF. Methods: Two hundred fifty-nine US hospitals participating in the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) submitted data on 48 612 patients with HF from March 1, 2003, through December 31, 2004. Admission, hospital, discharge care, and outcomes data were collected using a Web-based registry that provided real-time feedback on performance measures bench-marked to other hospitals. Process-of-care improvement tools, including evidence-based best-practice algorithms and customizable admission and discharge sets, were provided. Results: Provision of complete discharge instructions and smoking-cessation counseling increased significantly (from 46.8%-66.5% and 48.2%-75.6%, respectively; P<.001 for both). Left ventricular function assessment started at a high rate (89.3%) and improved to 92.1% (P<.001). Angiotensin-converting enzyme inhibitors were prescribed at discharge to 75.8% of eligible patients, which did not improve during the 2-year study. There were trends for reduction of in-hospital mortality, postdischarge death, and combined postdischarge death and rehospitalization and a significant reduction in mean length of stay. Use of preprinted admission order sets and/or discharge checklists increased from 35.6% to 54.1% and was associated with an increase in the use of evidence-based therapies and lower risk-adjusted in-hospital mortality. Conclusions: Participation in OPTIMIZE-HF was associated with an increase in use of evidence-based therapy, adherence to performance measures, and shorter lengths of stay in patients hospitalized with HF. Increased use of process-of-care improvement tools was associated with further improvements in quality of care. Trial Registration: clinicaltrials.gov Identifier NCT00344513.
UR - http://www.scopus.com/inward/record.url?scp=34547297943&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547297943&partnerID=8YFLogxK
U2 - 10.1001/archinte.167.14.1493
DO - 10.1001/archinte.167.14.1493
M3 - Article
C2 - 17646603
AN - SCOPUS:34547297943
SN - 0003-9926
VL - 167
SP - 1493
EP - 1502
JO - Archives of Internal Medicine
JF - Archives of Internal Medicine
IS - 14
ER -